ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc (ADIL)

1.02
0.01
(0.99%)
Cerrado 20 Noviembre 3:00PM
1.05
0.03
( 2.94% )
Pre Mercado: 5:18AM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
1.05
Postura de Compra
1.01
Postura de Venta
1.05
Volume Operado de la Acción
5,453
0.00 Rango del Día 0.00
0.765 Rango de 52 semanas 4.12
Capitalización de Mercado [m]
Precio Anterior
1.02
Precio de Apertura
-
Última hora de negociación
05:13:48
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
143,290
Acciones en circulación
6,405,781
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.28
Beneficio por acción (BPA)
-0.8
turnover
-
Beneficio neto
-5.12M

Acerca de Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sede
Wilmington, Delaware, USA
Fundado
-
Adial Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ADIL. The last closing price for Adial Pharmaceuticals was US$1.02. Over the last year, Adial Pharmaceuticals shares have traded in a share price range of US$ 0.765 to US$ 4.12.

Adial Pharmaceuticals currently has 6,405,781 shares in issue. The market capitalisation of Adial Pharmaceuticals is US$6.53 million. Adial Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.28.

ADIL Últimas noticias

Adial Pharmaceuticals Announces Positive Topline Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Confirmed relative bioavailability to the reference standard, dose proportional increases in pharmacokinetic exposure, and no food effect Marks final study needed for the upcoming FDA meeting for...

Adial Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

GLEN ALLEN, Va., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

GLEN ALLEN, Va., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.06-5.405405405411.111.280.99245117031.10840902CS
4-0.05-4.545454545451.11.280.96961962231.0836954CS
120.088.247422680410.971.280.93551432901.06097355CS
26-0.43-29.05405405411.4830.914556811.28224587CS
52-1.07-50.47169811322.124.120.76523259311.96885023CS
156-73.95-98.67578.50.76511574426.24334639CS
260-38.95-97.375401270.765101082024.3864689CS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
WORXSCWorx Corporation
US$ 2.03
(107.14%)
15.65M
PETWag Group Company
US$ 0.316
(50.40%)
17.62M
AKTSAkoustis Technologies Inc
US$ 0.1251
(43.63%)
55.43M
ESGROEnstar Group Ltd
US$ 28.00
(40.92%)
28
CCECCapital Clean Energy Carriers Corporation
US$ 24.99
(34.72%)
9
WSBFWaterstone Financial Inc
US$ 9.00
(-40.98%)
4
TRSTriMas Corporation
US$ 15.62
(-40.79%)
3
BCAXBicara Therapeutics Inc
US$ 11.00
(-40.15%)
212
PYXSPyxis Oncology Inc
US$ 2.40
(-37.17%)
208.06k
XNCRXencor Inc
US$ 15.11
(-36.30%)
2
AKTSAkoustis Technologies Inc
US$ 0.1251
(43.63%)
55.43M
PETWag Group Company
US$ 0.316
(50.40%)
17.62M
WORXSCWorx Corporation
US$ 2.03
(107.14%)
15.65M
XTKGX3 Holdings Company Ltd
US$ 0.073
(-18.89%)
10.75M
CRKNCrown Electrokinetics Corporation
US$ 1.00
(27.28%)
5.39M

ADIL Discussion

Ver más
Awl416 Awl416 4 meses hace
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Looks like green very soon !
👍️0
FROZENFLAME FROZENFLAME 4 meses hace
Interesting !
👍️0
glenn1919 glenn1919 4 meses hace
ADIL............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 4 meses hace
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Source: GlobeNewswire Inc.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the progression to the second cohort in the pharmacokinetics study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients (defined as < 10 drinks/drinking day), following the successful completion of the first cohort. Topline results from both cohorts are expected to be announced during the fourth quarter of 2024.
Cary Claiborne, President and Chief Executive Officer of Adial commented, “We are pleased with the progress of our pharmacokinetics study of AD04. The successful completion of the first cohort allows us to advance to the second cohort as planned, staying on track with our projected timeline. The results from both cohorts will offer invaluable insights that are critical for the design of our upcoming Phase 3 Clinical Trial. We anticipate engaging with the FDA following receipt of the topline data from this study and seek their feedback on the overall design of our Phase 3 program.”

The pharmacokinetics study was initiated in June 2024 and is expected to be completed during the fourth quarter of 2024. The single-center open-label relative bioavailability and dose proportionality study will enroll up to 30 healthy adult volunteers and compare the pharmacokinetic profile of AD04 when administered as an oral dose of 0.33 mg with or without food against a reference standard product. This study will provide valuable information on the pharmacokinetic properties of AD04.

👍️0
Monksdream Monksdream 4 meses hace
ADIL under $2
👍️0
Monksdream Monksdream 5 meses hace
ADIL under $2
👍️0
glenn1919 glenn1919 6 meses hace
ADIL....................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 7 meses hace
ADIL under $1
👍️0
Awl416 Awl416 7 meses hace
What leaked?
👍️0
44Skell 44Skell 7 meses hace
Where to now ADIL?
👍️0
Klinsmann Klinsmann 7 meses hace
Sorry to say, I was deadly wrong on this one... But I´m holding and adding.
👍️0
Klinsmann Klinsmann 7 meses hace
Holding up very well. And flagging for the next uptick. Jep, it‘s supposed to happen…
👍️ 1
44Skell 44Skell 7 meses hace
Isn’t this stock suppose to be ticking up
👍️0
Invest-in-America Invest-in-America 7 meses hace
ADIL: Boy, am I eatin' 'CROW' on this one, or what!!! (Likely Close today at $5.00, just to humiliate me even more!!!)


"Heck, I trash a stock, & then it soars to the MOON!!! I HATE when this happens!!! NO RESPECT, at all!!!"
🤣 1
glenn1919 glenn1919 7 meses hace
ADIL...............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 7 meses hace
ADIL: This is what one gets behind 'investing' in a mere Ultra-Pre-Human-Trials, Petri Dish, Test Tude, Theoretical Journal Paper, and otherwise, 'THE-GREAT-ALCOHOL-ADDICTION-MAYBE-COULD-BE-MIGHT-BE-YEARS-FROM-NOW-CURE-OF-THE-WEEK', fluffy, Wall Street 'news' routine.
👍️0
TheFinalCD TheFinalCD 7 meses hace
tHANKS adiL 1.82
👍️0
Klinsmann Klinsmann 7 meses hace
Congrats- chart looks primed for more…
👍️0
TheFinalCD TheFinalCD 7 meses hace
filled 1.97 on that dip
👍️0
TheFinalCD TheFinalCD 7 meses hace
$ADIL 2.54 LET MORE GO, WHAT A GREAT STOCK TO TRADE

https://finviz.com/quote.ashx?t=ADIL&ty=c&ta=1&p=d

https://twitter.com/READY_2_PROFIT/status/1778040234178920694
👍️0
TheFinalCD TheFinalCD 7 meses hace
CONGRAT$
👍️0
TheFinalCD TheFinalCD 7 meses hace
nhod https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174209695
👍️0
Klinsmann Klinsmann 7 meses hace
Overdue- go time again!
👍️0
Awl416 Awl416 7 meses hace
What leaked?
👍️0
Klinsmann Klinsmann 8 meses hace
Added more shares - rumors about a big pharma deal hopefully get published soon…
👍️0
Monksdream Monksdream 8 meses hace
ADIL 10Q due 3/18
👍️0
maent maent 9 meses hace
I'm totally out. It was a nice bounce. We will see if it drops back into a buy zone. GL all.
👍️0
Bill_ENG Bill_ENG 9 meses hace
Except for the failed Phase III and then the company not doing anything except for a reverse split in two years.

They need to run more trials it will take 3 to 4 years to prove effectiveness and a higher probability it will fail those trials.

Having a patent on something that doesn't work is not worth much.

Jmho
👍️0
glenn1919 glenn1919 9 meses hace
ADIL................................................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Lottoplay Lottoplay 9 meses hace
“AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity” my projected selling price just went higher! I didn’t know it treated gambling and obesity in addition to alcoholism and opioid addiction! BOOM!!!
👍️0
Lottoplay Lottoplay 9 meses hace
BOOM! Posted yesterday! “ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that!”
👍️0
maent maent 9 meses hace
I'm now looking for a nice bounce over $5
👍️0
BurgerKing82 BurgerKing82 9 meses hace
This one looks good
👍️0
Lottoplay Lottoplay 9 meses hace
$ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that! 🚀
👍️0
Awl416 Awl416 9 meses hace
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
👍️0
maent maent 9 meses hace
I'm looking for a nice bounce back over $1
👍️0
Monksdream Monksdream 9 meses hace
ADIL new 52 week low
👍️0
maent maent 9 meses hace
My stop loss hit at 1.04
👍️0
Monksdream Monksdream 9 meses hace
ADIL new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
ADIL new 52 week low
👍️0
maent maent 9 meses hace
Looks like a nice entry point here.
👍️0
eb0783 eb0783 9 meses hace
Cat got your tongue?
👍️0
Monksdream Monksdream 9 meses hace
ADIL new 52 week low
👍️0
Monksdream Monksdream 9 meses hace
ADIL new 52=week low
👍️0
Monksdream Monksdream 10 meses hace
ADIL new 52 week low
🌈 1 🍆 1 👎️ 1 🩳 1
Monksdream Monksdream 10 meses hace
ADIL new 52 week high
👍️0
Monksdream Monksdream 10 meses hace
ADIL new 52 week low
👍️0
Muhbruh Muhbruh 11 meses hace
https://twitter.com/StocksGambino/status/1740752941974438075
👍️0
Zorro Zorro 11 meses hace
Volume picking up but also dropping in price. Looks like there is historic support in the 1.80 area.
👍️0

Su Consulta Reciente

Delayed Upgrade Clock